Nutex Health Inc. - Common Stock (NQ:NUTX)

210.10 -2.53 (-1.19%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nutex Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

2 Stocks to Buy Hand Over Fist in October ↗

October 08, 2026

Nutex Health and Elevance Health may be underpriced, despite their share growth this year.

Via The Motley Fool

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Net income surged $65.8M as contract costs fell and volumes climbed.

Via The Motley Fool

Topics Earnings

Nutex Health Q2 Earnings Call Highlights ↗

August 07, 2026

Nutex Health (NASDAQ:NUTX) reported higher second-quarter profitability and adjusted EBITDA despite lower revenue, as the company benefited from reduced arbitration-related costs, lower stock-based...

Via MarketBeat

Topics Earnings

Nutex Health (NASDAQ:NUTX) Faces Mixed Q1 Results as Revenue Miss Offsets Strong EPS Beat ↗

April 30, 2026

Via Chartmill

NUTEX HEALTH INC (NASDAQ:NUTX) Identified as a High-Growth Candidate by Navellier's "Little Book" Method ↗

March 04, 2026

Via Chartmill

Nutex Health Inc (NASDAQ:NUTX) Emerges as a High-Growth Candidate Using Navellier's Rules ↗

February 11, 2026

Via Chartmill

Nutex Health Inc (NASDAQ:NUTX) Passes Louis Navellier's "Little Book" Growth Stock Screen ↗

January 19, 2026

Via Chartmill

Nutex Health NUTX Q1 2025 Earnings Transcript ↗

May 04, 2026

Nutex Health NUTX Q1 2025 Earnings Transcript

Via The Motley Fool

Nutex Health NUTX Q2 2025 Earnings Transcript ↗

May 04, 2026

Nutex Health NUTX Q2 2025 Earnings Transcript

Via The Motley Fool

Nutex (NUTX) Q1 2026 Earnings Call Transcript ↗

May 01, 2026

Nutex (NUTX) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

Lowey Dannenberg, P.C. is Investigating Nutex Health, Inc. (Nasdaq: NUTX) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

March 13, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

March 10, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Nutex Health (NUTX) Q4 2025 Earnings Transcript ↗

March 09, 2026

Nutex Health (NUTX) Q4 2025 Earnings Transcript

Via The Motley Fool

Topics Economy

These stocks are moving in today's pre-market session ↗

March 06, 2026

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

March 05, 2026

Via Chartmill

InvestorNewsBreaks – Nutex Health Inc. (NASDAQ: NUTX) Reopens Bayou City ER & Hospital in Humble Texas

February 13, 2026

Via Investor Brand Network

Nutex Health Inc (NASDAQ:NUTX) Emerges as a Top Growth Stock Using Louis Navellier's "Little Book" Strategy ↗

December 29, 2025

Nutex Health stock shows explosive growth, soaring earnings, and strong cash flow, fitting a proven growth investing strategy for further research.

Via Chartmill

NUTEX HEALTH INC (NASDAQ:NUTX) Emerges as a High-Growth Momentum Stock Meeting Minervini's Trend Template ↗

December 19, 2025

Nutex Health (NUTX) exemplifies a high-growth momentum stock meeting strict technical trend criteria, showing strong price action and surging earnings.

Via Chartmill

Nutex Health Inc (NASDAQ:NUTX) Screens as a High-Growth Stock Using Navellier's 'Little Book' Method ↗

December 08, 2025

Nutex Health (NUTX) emerges as a high-growth stock candidate, showing explosive sales, earnings growth, widening margins, and strong cash flow per Navellier's screening method.

Via Chartmill

Capybara Research Goes Short On NUTX Stock, Alleges Fraudulent Business Practices ↗

November 25, 2025

Capybara stated that more than a dozen Nutex partners, including physicians, medical directors, and board members, have accused Nutex and its CEO and Chairman, Thomas Vo, of wrongdoing, including...

Via Stocktwits

Topics Fraud

Top stock movements in today's session. ↗

November 20, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Keep an eye on the top gainers and losers in Thursday's session. ↗

November 20, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 20, 2025

Via Benzinga

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗

November 20, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

November 19, 2025

In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

November 19, 2025

Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 19, 2025

Via Benzinga

Why Did Nutex Health's (NUTX) Shares Soar 21% After Hours? ↗

November 18, 2025

Nutex Health's shares jumped nearly 21% in after-hours trading following strong second-quarter results and a new $25 million stock buyback program.

Via Benzinga

NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 23, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.